How do stem cells actually regrow hair in baldness?
Stem cells work by waking up dormant hair follicle cells and creating a better environment for growth. In people with androgenetic alopecia (common baldness), hair follicle stem cells remain inactive and fail to regenerate new hairs [4]. Stem cell therapies aim to reactivate these cells or replace them with fresh ones. For instance, one study found that stem cell-derived exosomes (tiny signaling particles) accelerated hair regrowth in mice by boosting key growth pathways like Wnt/β-catenin, which is critical for follicle cycling [7]. Another study showed that stem cells from hair follicles themselves can 'home' back to their natural niches in the scalp, where they then stimulate prolonged hair growth [11].
The process isn't just about adding cells—it's about signaling. A 2024 review explains that stem cells secrete growth factors that activate dermal papilla cells (the command center of the hair follicle) and improve blood supply to the scalp [12]. For example, in a rat model of alopecia, stem cell exosomes raised levels of TGF-β and PDGF—two proteins that promote follicle regeneration and blood vessel formation [8]. This dual action (cell replacement plus chemical signaling) is why stem cell therapies can potentially outperform standard treatments like minoxidil, which only stimulate existing follicles.
Does the evidence prove stem cells work for human baldness?
The strongest human evidence comes from studies on specific types of hair loss, but the overall picture is mixed. In a 2024 study of 60 patients with scalp scars, those who received stem cell injections before a hair transplant saw a 45% increase in hair density and an 87% graft survival rate, compared to 25% and 60% in the control group [2]. Another case report showed that a combination of stem cell types reversed hair loss caused by a COVID-19 vaccine, with no side effects after 12 weeks [1]. A review of multiple studies found that autologous stem cell therapy (using the patient's own cells) led to a 29% increase in hair density over six months [3].
However, these results come with important caveats. Most studies are small—the scarred-tissue study had only 30 patients per group [2], and the vaccine case was a single patient [1]. Many promising findings come from animal models, like mice [7][10] or rats [8], which don't always translate to humans. A 2023 review notes that while stem cell therapy is 'promising,' it is still an emerging field, and larger, longer-term human trials are needed [9]. So, while the evidence points toward real potential, it's not yet strong enough to recommend stem cell treatments as a routine solution for common male pattern baldness.
Which type of stem cell works best for hair regrowth?
Researchers have tested several stem cell sources, and they don't all perform equally. The most common types are mesenchymal stem cells (from umbilical cord, bone marrow, or fat), hair follicle stem cells (from the scalp itself), and even menstrual stem cells. In a direct comparison, stem cells from dermal papilla cells (the core of the hair follicle) showed better targeting and uptake by hair follicles than those from skin or fat cells [6]. Another study found that exosomes from umbilical cord stem cells accelerated hair regrowth in mice by activating follicle stem cells and the Wnt pathway [7].
A novel approach using menstrual stem cells (Crown-X) increased human dermal papilla cell growth by 63% in lab tests, suggesting a non-invasive option [5]. However, the most effective strategy may be combining stem cells with other treatments. For example, one study used stem cell injections alongside a hair transplant to dramatically improve results on scarred tissue [2]. Another engineered stem cell nanovesicles with a specific protein (HDAC1) to boost hair regeneration through p53 and Wnt pathways [6]. The takeaway: no single stem cell type has been proven 'best' in head-to-head human trials, but those derived from hair follicles or umbilical cord appear most promising in early research.
About These Sources
This answer is built on 12 peer-reviewed studies — published from 2022 to 2026, 9 from 2024 or later, 6 in Q1 journals, collectively cited 89 times — selected as the most relevant from 15 studies that passed quality screening, drawn from 85 papers retrieved from a database of over 500 million.
Sources used in this answer
Stem cell therapy alleviates hair loss caused by COVID-19 vaccination
A case report of one patient with COVID-19 vaccine-induced hair loss showed that injections of stem cells (CD34+ and umbilical cord mesenchymal) improved hair loss after 12 weeks with no significant side effects.
Stem cell therapy prior to follicular unit hair transplantation on scarred tissue: a novel approach to a successful procedure
In a study of 60 patients with scalp scars, those who received stem cell therapy before a hair transplant had 45% higher hair density and 87% graft survival, compared to 25% and 60% in the control group.
ThP2.15 - Investigating the use of autologous stem cell therapy in the treatment of Androgenetic Alopecia
A review of studies on androgenetic alopecia found that autologous stem cell therapy increased hair density by 29% over six months, with advantages like fewer biopsies and no donor follicle limits.
Effectiveness of a Novel Compound HAIR & SCALP COMPLEX on Hair Follicle Regeneration
An in vitro study showed that a compound called HAIR & SCALP COMPLEX (containing colostrum exosomes and growth factors) significantly increased hair bulb growth and dermal papilla regeneration compared to other treatments.
Crown-X: A Novel Menstrual Stem Cell-Based Therapy for Hair Regeneration in Male Pattern Baldness
In lab tests, Crown-X (a formulation with menstrual stem cells) increased human dermal papilla cell proliferation by 63% at a 0.1% concentration after 72 hours, suggesting a non-invasive hair restoration option.
HDAC1-overexpressing dermal papilla cell-derived extracellular vesicles modulate p53 and Wnt/β-catenin signaling to rescue hair follicle regeneration in androgenetic alopecia
Engineered nanovesicles from dermal papilla cells overexpressing HDAC1 improved cell proliferation and migration, and promoted hair follicle regeneration in mice by modulating p53 and Wnt/β-catenin pathways.
Stimulation of mouse hair regrowth by exosomes derived from human umbilical cord mesenchymal stem cells
In a mouse model, exosomes from human umbilical cord mesenchymal stem cells accelerated hair regrowth by upregulating hair follicle stem cell markers and the Wnt/β-catenin pathway.
Hypoxia-Induced Mesenchymal Stem Cell-Derived Exosome Enhance TGF-β, PDGF, and Hair Growth in Alopecia-Like Rat Models
In a rat model of alopecia, hypoxia-induced stem cell exosomes (200 µL daily for 14 days) significantly increased TGF-β and PDGF levels in skin, which are linked to improved hair growth.
Status of research on the development and regeneration of hair follicles
A review of hair follicle development and regeneration concluded that stem cell therapy is a promising emerging treatment for hair loss, but larger human trials are still needed.
Alpinetin promotes hair regeneration via activating hair follicle stem cells
In mice, topical application of Alpinetin (a plant compound) promoted anagen initiation and delayed catagen by activating Lgr5+ hair follicle stem cells via Wnt signaling, with no cytotoxicity.
The homing of exogenous hair follicle mesenchymal stem cells into hair follicle niches
In mice, injected hair follicle mesenchymal stem cells (dermal papilla and sheath cells) homed to their natural niches, enhancing hair growth and prolonging anagen phases, with the CXCL13/CXCR5 pathway mediating this homing.
Stem Cell therapy for Hair Loss
A review of stem cell therapies for hair loss highlighted that stem cells from adipose tissue, bone marrow, and hair follicles promote hair growth by activating dermal papilla cells and enhancing follicular regeneration.